/People

John D. Lewis

Founder

Executive Officer, Director at Oncosenx · Executive at Oisin Biotechnologies · Founder, Board Chair & CEO at NanoStics

Edmonton, Alberta, Canada

FoundedNanoStics

Find your path to John

1,006 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.

Ed SimcoxunlockedJohn: together at Oisin Biotechnologies (2020–2026)
×10John: together at University of Alberta
John: together at Scripps Research

About

John D. Lewis holds the Bird Dogs Chair in Translational Oncology at the University of Alberta. His research focuses on cancer metastasis, using advanced live imaging techniques, along with the application of nanotechnology and imaging to chronic diseases including aging and cancer. His research group works to translate new diagnostics and treatments into clinical use.

Executive Officer, Director at Oncosenx

Intro paths

→

In turn, John can intro founders to Oncosenx's investors below.

Co-founders at Oncosenx

MSMatt Scholz
Matt ScholzExecutive Officer, Director

Executive at Oisin Biotechnologies

Co-founders at Oisin Biotechnologies

MSMatthew Scholz
Matthew ScholzExecutive Officer, Director

Founder, Board Chair & CEO at NanoStics

Intro paths

→

In turn, John can intro founders to NanoStics's investors below.

Co-founders at NanoStics

RP
Robert PaproskiCo-founder & Chief Technology Officer

Experience

  1. University of AlbertaBird Dogs Chair in Translational Oncologycurrent2022 — presentEdmonton, Alberta, Canada
  2. University of AlbertaProfessorcurrent2019 — presentGreater Edmonton Metropolitan Area
  3. University of AlbertaFrank and Carla Sojonky Chair in Prostate Cancer Research2012 — 2022Greater Edmonton Metropolitan Area
  4. University of AlbertaAssociate Professor2012 — 2018Edmonton, Canada Area
  5. Entos PharmaceuticalsFounder, CEOcurrent2016 — presentEdmonton, AB
  6. Aegis Life, Inc.Founder, CEOcurrent2020 — presentSan Diego, California, United States
  7. OncoSenXFounder, CSOcurrent2018 — presentSeattle, Washington
  8. Nanostics IncFounder, CEOcurrent2017 — presentEdmonton, AB
  9. Oisin BiotechnologiesCSOcurrent2016 — presentSeattle
  10. Alberta Prostate Cancer Research InitiativeFounding Chair2012 — 2022Alberta, Canada
  11. Innovascreen IncCEO2005 — 2019
  12. University of Western OntarioAssistant Professor2006 — 2011
  13. London Health Sciences CentreRobert Hardie Chair in Translational Prostate Cancer Research2006 — 2011

Skills & more

Cancer Research

From John's professional profile.

Frequently asked questions

Who is John D. Lewis?
John D. Lewis holds the Bird Dogs Chair in Translational Oncology at the University of Alberta. His research focuses on cancer metastasis, using advanced live imaging techniques, along with the application of nanotechnology and imaging to chronic diseases including aging and cancer. His research group works to translate new diagnostics and treatments into clinical use.
Where does John D. Lewis work?
John D. Lewis is Founder, Board Chair & CEO of NanoStics and Executive at Oisin Biotechnologies.
What companies did John D. Lewis found?
John D. Lewis founded NanoStics.
Where did John D. Lewis go to school?
John D. Lewis studied at Scripps Research (PDF, Nanotechnology); University of Victoria (Ph.D., Biochemistry); Western University (BSc HONS, Genetics).

Founder mafias

Same school

Shared employers